Hot Issues
Take action!
Contact your legislators to stop fake online pharmacies and report social media drug sellers to the DEA
Follow us: Twitter | YouTube | Facebook | LinkedIn | Instagram
Information provided to WHO by AstraZeneca, the genuine manufacturer of IMFINZI, has confirmed that the products identified in this Alert are falsified. Laboratory analysis of samples of the falsified IMFINZI have been carried out by AstraZeneca. The analysis confirmed that the vials of the falsified product contained no active pharmaceutical ingredient.
WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.
As prescription medications containing fentanyl and other illegal substances are becoming more widely accessible worldwide, a global crackdown on illicit drug precursors is leading cartels to experiment with the contents of their products.
FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was found at 5.24 mg/g or 1.84 mg/capsule. Dexamethasone was found at 2.22 mg/g or 0.780 mg/capsule. Chlorpheniramine was found at 4.38 mg/g or 1.54 mg/capsule.
Two new cases involving black market medicine in Texas and Tennessee, and CPB seized thousands of pills in Laredo.
The lawsuit against Snap may proceed and the ADA issued a statement about compounded GLP-1 medicines.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
The American Diabetes Association warned patients about non-FDA approved GLP-1 injections. Learn more.
The FTC says PBMs are driving up drug costs. Learn how.
Watch to see the illegal medicines CBP and FDA are seizing in Ohio.
Click the images below to see more recent videos.